Innovation Center for Wound Repair, Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China.
West China Medical School, Sichuan University, Chengdu, 610041 Sichuan, China.
J Diabetes Res. 2022 Sep 26;2022:9742665. doi: 10.1155/2022/9742665. eCollection 2022.
To reduce diabetic foot ulcer (DFU) occurrence or recurrence, diabetic therapeutic footwear is widely recommended in clinical practice for at-risk patients. However, the effectiveness of therapeutic footwear is controversial. Thus, we performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to examine whether special therapeutic footwear could reduce the incidence of DFU.
We systematically searched multiple electronic databases (Medline, EMBASE, and EMB databases) to identify eligible studies published from inception to June 11, 2021. The database search, quality assessment, and data extraction were independently performed by two reviewers. Efficacy (i.e., incidence of DFU) was explored using the R'meta' package (version 4.15-1). To obtain more robust results, the random-effects model and the Hartung-Knapp-Sidik-Jonkman method were selected to assess pooled data. Metaregression analysis and sensitivity analysis were performed to explore heterogeneity, and publication bias was assessed by a visual inspection of funnel plots and the AS-Thompson test.
Eight RCTs with a total of 1,587 participants were identified from the search strategy. Compared with conventional footwear, special therapeutic footwear significantly reduced the incidence of DFU (RR 0.49; 95% CI, 0.28-0.84), with no evidence of publication bias ( = 0.69). Unexpectedly, the effectiveness of special therapeutic footwear had a reverse correlation with the intervention time (coefficient = 0.085, < 0.05) in the metaregression analysis.
Special therapeutic footwear with offloading properties is effective in reducing the incidence of DFU. However, the effect may decrease gradually over time. Despite undefined reasons, the optimal utility time and renewal frequency of special therapeutic footwear should be considered.
为了降低糖尿病足溃疡(DFU)的发生或复发,临床实践中广泛推荐为高危患者使用糖尿病治疗性鞋具。然而,治疗性鞋具的疗效存在争议。因此,我们进行了系统评价和随机对照试验(RCT)的荟萃分析,以检验特殊治疗性鞋具是否能降低 DFU 的发生率。
我们系统地检索了多个电子数据库(Medline、EMBASE 和 EMB 数据库),以确定从建库到 2021 年 6 月 11 日发表的合格研究。数据库检索、质量评估和数据提取由两名评审员独立进行。使用 R‘meta’包(版本 4.15-1)探索疗效(即 DFU 的发生率)。为了获得更稳健的结果,选择随机效应模型和 Hartung-Knapp-Sidik-Jonkman 方法来评估汇总数据。进行荟萃回归分析和敏感性分析以探索异质性,并通过漏斗图和 AS-Thompson 检验评估发表偏倚。
从检索策略中确定了 8 项 RCT,共纳入 1587 名参与者。与常规鞋具相比,特殊治疗性鞋具显著降低了 DFU 的发生率(RR 0.49;95%CI,0.28-0.84),且无发表偏倚的证据( = 0.69)。出乎意料的是,在荟萃回归分析中,特殊治疗性鞋具的有效性与干预时间呈反向相关(系数=0.085, < 0.05)。
具有减压特性的特殊治疗性鞋具可有效降低 DFU 的发生率。然而,其效果可能会随时间逐渐减弱。尽管原因尚未明确,但应考虑特殊治疗性鞋具的最佳使用时间和更新频率。